Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ILMN
ILLUMINA, INC.
NASDAQ
$215.59
▼ DOWN 5.31% (-12.10)

KEY STATISTICS

Market Cap$32.62 B
52w High$231.81
52w Low$88.00
Dividend Yield—
Frequency—
P/E42.86
Volume1.79M
Shares Out.151.30M

COMPANY

LEADERSHIP

Jacob Thaysen
CHIEF EXECUTIVE
Jacob Thaysen

COMPENSATION 2026

Salary$1,000,000
Stock Awards$8,763,122
Incentive Plan Pay$1,155,000
All Other Comp.$100,773
Total$11,018,895

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 28, 2000
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
8,600

PRICE TARGET

Target High$230.00
Target Low$155.00
Target Median$210.00
Target Consensus$200.14

UPCOMING EARNINGS

DateOct 29, 2026
DayThursday
Rev. Est.$1.15B
OCT
29
THU

SPLIT RECORD

DATETYPERATIO
2008-09-23Forward2:1

PRICE

$215.59 ▼ DOWN 5.31% (−$12.10)
OVERLAYS
$216$219$2229:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM215.59

About Illumina, Inc.

https://www.illumina.com ↗

Illumina, Inc. provides sequencing and genomic analysis solutions, including instruments, consumables, and services, serving research, clinical, and industrial markets worldwide.

INDUSTRY

Medical - Diagnostics & Research

A PRODUCT ILLUMINA, INC. IS KNOWN FOR

NovaSeq X Plus
NovaSeq X Plus

The NovaSeq X Plus is Illumina’s most powerful high-throughput DNA sequencer, capable of sequencing over 20,000 genomes annually, supporting genomic research, pharma, and academia in advancing life sciences and precision medicine.

COMPETITORS

COMPETITOR
A COMPARE
PACB COMPARE
QGEN COMPARE
TMO COMPARE
TXG COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Sequencing$1B $1.06B ▲$995M ▼$1.05B ▲
Microarray$83M $94M ▲$96M ▲$105M ▲

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
Americas$612M $638M ▲— —
EMEA$309M $352M ▲$356M ▲$368M ▲
Asia Pacific$111M $113M ▲$93M ▼$82M ▼
CHINA$52M $56M ▲$52M ▼$56M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
670
LISTED HERE
26
RANKED BY POSITION SIZE
BSCP
0.30% · 6.9M
XMH.TO
0.93% · 5.3M
VTI
0.04% · 4.6M
MDY
0.94% · 1.1M
FBT
3.63% · 476.0K
VETS
1.16% · 461.7K
ARKG
4.08% · 382.5K
FMDE
0.80% · 290.1K
AIAI.L
2.11% · 197.6K
ROBO
2.07% · 190.2K
CGMM
1.10% · 182.1K
SCHX
0.05% · 162.3K
SCRD
0.43% · 162.0K
BAFE
0.89% · 136.0K
DFAC
0.05% · 102.9K
GSLC
0.15% · 100.1K
JMEE
0.76% · 99.7K
WTAI.L
1.48% · 93.2K
RECS
0.29% · 77.7K
BBH
3.45% · 72.8K
XDWH.DE
0.39% · 70.3K
HMWD.L
0.08% · 64.3K
U127.L
0.10% · 56.5K
JHMM
0.19% · 51.6K
FMTM
3.60% · 46.2K
PB
PBPH
0.75% · 34.4K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
100.00%
HOLDERS
1,398
TOP 12 OF 1,398 · RANKED BY POSITION SIZE
Metatron Capital Sicav Plc
156.3M sh · $760.8M
Capital World Investors
20.1M sh · $2.64B
Blackrock, Inc.
19.2M sh · $3.37B
Blackrock Inc.
18.1M sh · $1.89B
Vanguard Group Inc
14.6M sh · $1.39B
State Street Corp
6.5M sh · $1.14B
Wcm Investment Management, LLC
6.2M sh · $1.12B
Blackrock Fund Advisors
4.7M sh · $601.25M
Sessa Capital Im, L.P.
4.7M sh · $445.1M
Fmr LLC
4.5M sh · $795.35M
Aqr Capital Management LLC
4.4M sh · $580.53M
Loomis Sayles & Co L P
4.3M sh · $407.18M

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity5
Return On Assets5
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Gilbert Cisneros
Gilbert Cisneros
Purchase
2026-02-10
 Ro Khanna
Ro Khanna
Sale
2026-01-29
 Lisa McClain
Lisa McClain
Purchase
2025-06-09
 Thomas H. Kean
Thomas H. Kean
Purchase
2025-04-01

INSIDER TRADES

★
DIRECTOR
Meister Keith A.
Sale · 92.8K shares
2026-08-25
★
DIRECTOR
Meister Keith A.
Sale · 38.2K shares
2026-08-25
★
DIRECTOR
Meister Keith A.
Sale · 42 shares
2026-08-25
★
DIRECTOR
Meister Keith A.
Sale · 53.1K shares
2026-08-26

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OUTPERFORM 3
OVERWEIGHT 2
HOLD 2
BUY 2
NEUTRAL 2
SELL 1
UNDERWEIGHT 1
13 GRADES IN THE LAST 12 MONTHS
Piper Sandler OVERWEIGHT Canaccord Genuity HOLD Citigroup SELL JP Morgan OVERWEIGHT RBC Capital OUTPERFORM Barclays UNDERWEIGHT Guggenheim BUY TD Cowen HOLD

SECTORS PEERS

PEERPRICE
WAT$414.69COMPARE
LH$335.11COMPARE
DGX$242.76COMPARE
WST$337.47COMPARE
THC$266.80COMPARE
GMAB$33.23COMPARE
ZBH$100.91COMPARE
MEDP$600.65COMPARE